PICO Portalanswers from OpenAlex & ORCID
Alexander M. Lesokhin
ResearcherPublications, citations & collaboration network
Alexander M. Lesokhin is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Alexander M. Lesokhin have?
PICO Portalindexed works
Alexander M. Lesokhin has 570 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Alexander M. Lesokhin have?
PICO Portalcitation count
Alexander M. Lesokhin has 25,161 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Alexander M. Lesokhin?
PICO Portalh-index
Alexander M. Lesokhin has an h-index of 58 in OpenAlex.
What is the i10-index of Alexander M. Lesokhin?
PICO Portali10-index
Alexander M. Lesokhin has an i10-index of 159 in OpenAlex.
What is the ORCID of Alexander M. Lesokhin?
PICO Portalorcid
The ORCID for Alexander M. Lesokhin is on the source record.
What is the OpenAlex record for Alexander M. Lesokhin?
PICO Portalopenalex
The OpenAlex for Alexander M. Lesokhin is on the source record.
What are the most-cited papers on Alexander M. Lesokhin?
PICO Portalmost cited works
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, A. Keith Stewart, Parameswaran Hari, Myo Htut, Alexander M. Lesokhin, Abhinav Deol, Nikhil C. Munshi, Elizabeth O’Donnell, David Avigan, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Yunsi Olyslager, Arnob Banerjee, Carolyn C. Jackson, Jenna D Goldberg, Jordan M. Schecter, William Deraedt, Sen Hong Zhuang, Jeffrey R. Infante, Dong Geng, Xiaoling Wu, Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Yi Lin, Thomas G. Martin, Sundar Jagannath
Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M. Woo, Tunç Iyriboz, Darragh Halpenny, Jane Cunningham, Jamie E. Chaft, Neil H. Segal, Margaret K. Callahan, Alexander M. Lesokhin, Jonathan E. Rosenberg, Martin H. Voss, Charles M. Rudin, Hira Rizvi, Xue Hou, Katherine Rodríguez, Melanie Albano, Ruth-Ann Gordon, Charles Leduc, Natasha Rekhtman, Bianca Harris, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino, Benjamin Y. Kong, Jedd D. Wolchok, Michael A. Postow, Georgina V. Long, Matthew D. Hellmann
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, H. Miles Prince, Rubén Niesvizky, Paula Rodríguez‐Otero, Joaquín Martínez‐López, Guenther Koehne, Cyrille Touzeau, Yogesh Jethava, Hang Quach, Julien Depaus, Hisayuki Yokoyama, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Salomon Manier, Noopur Raje, Shinsuke Iida, Marc S. Raab, Emma Searle, Eric Leip, Sharon T. Sullivan, Umberto Conte, Mohamed Elmeliegy, Akos Czibere, Andrea Viqueira, Mohamad Mohty